BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Prognosis
114 results:

  • 1. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies.
    Yokota E; Iwai M; Yukawa T; Naomoto Y; Haisa M; Monobe Y; Takigawa N; Fukazawa T; Yamatsuji T
    Cancer Lett; 2024 Apr; 588():216816. PubMed ID: 38499265
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CD133 significance in glioblastoma development: in silico and in vitro study.
    Abdoli Shadbad M; Nejadi Orang F; Baradaran B
    Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
    Shirai Y; Ueno T; Kojima S; Ikeuchi H; Kitada R; Koyama T; Takahashi F; Takahashi K; Ichimura K; Yoshida A; Sugino H; Mano H; Narita Y; Takahashi M; Kohsaka S
    J Neurooncol; 2024 Mar; 167(1):75-88. PubMed ID: 38363490
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
    PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
    Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets.
    Yang Y; Li H; Zheng D; Li X; Liu H
    Aging (Albany NY); 2023 Nov; 15(22):13345-13367. PubMed ID: 38019470
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant.
    Tran S; Thomas A; Aliouat I; Karachi C; Lozano F; Mokhtari K; Dehais C; Feuvret L; Carpentier C; Giry M; Doukani A; Lerond J; Marie Y; Sanson M; Idbaih A; Carpentier A; Hoang-Xuan K; Touat M; Capelle L; Bielle F
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12928. PubMed ID: 37503540
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeting cdk4/6 in glioblastoma
    Zhang X; Ning L; Wu H; Yang S; Hu Z; Wang W; Cao Y; Xin H; You C; Lin F
    Nanoscale; 2023 Aug; 15(30):12518-12529. PubMed ID: 37278298
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine tumors and Metastases.
    Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
    Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel cdk4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.
    Zuo P; Li Y; Wang T; Lin X; Wu Z; Zhang J; Liao X; Zhang L
    J Neurooncol; 2023 May; 163(1):159-171. PubMed ID: 37133743
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutational landscape of primary spinal cord astrocytoma.
    Cheng L; Zhang F; Zhao X; Wang L; Duan W; Guan J; Wang K; Liu Z; Wang X; Wang Z; Wu H; Chen Z; Teng L; Li Y; Xiao F; Fan T; Jian F
    J Pathol; 2023 Jul; 260(3):317-328. PubMed ID: 37114614
    [TBL] [Abstract] [Full Text] [Related]  

  • 13.
    De Rosa P; Severi F; Zadran SK; Russo M; Aloisi S; Rigamonti A; Capranico G; Milazzo G; Perini G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982482
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical outcomes and risk factors associated with poor prognosis after endoscopic resection of 10-20 mm rectal neuroendocrine tumors: a multicenter, retrospective study of 10-year experience.
    Goo JJ; Baek DH; Kim HW; Lee HS; Lee JY; Park SB; Song GA; Lee SH; Lee JH;
    Surg Endosc; 2023 Jul; 37(7):5196-5204. PubMed ID: 36947224
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
    Huang J; Fu X; Xue Q; Ma P; Yin Y; Jiang M; Lu Y; Ying Q; Jiang J; He H; Wu D
    Dis Markers; 2023; 2023():7146589. PubMed ID: 36852158
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Assessment of Social Vulnerability in Pediatric Head and Neck Cancer Care and prognosis in the United States.
    Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
    Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
    J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Does the LHPP gene share a common biological function in pancancer progression?
    Guo K; Tian W; Wang H; Chang D; Dou Y; Yuan J; Chen Y; Hou B
    BMC Med Genomics; 2022 Nov; 15(1):239. PubMed ID: 36376886
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of cdk4.
    Li K; Huang G; Wang Z; Yang R; Zhang W; Ni B; Guan J; Yi G; Li Z; Zhu Q; Peng Q; Yang L; Qi L; Liu Y
    Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166571. PubMed ID: 36244542
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.
    Sun TY; Zhao L; Van Hummelen P; Martin B; Hornbacker K; Lee H; Xia LC; Padda SK; Ji HP; Kunz P
    Endocr Relat Cancer; 2022 Dec; 29(12):665-679. PubMed ID: 36165930
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.